Pathology AI Platform
- Conditions
- Not Applicable
- Registration Number
- KCT0003460
- Lead Sponsor
- Seoul National University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Active, not recruiting
- Sex
- All
- Target Recruitment
- 6200
1. histologically confirmed neuroendocrine tumor of 5 organs (liver, large intestine, prostate gland, pancreas and biliary tract, kidney)
2. patients of above diagnosis whose operative tissue or biopsy tissue is conserved in biobanks of the SNUH (Seoul National University Hospital), SNUBH (Seoul National University Bundang Hospital), SMG-SNU Boramae Medical Center
3. all cases after February 2013 with written consent forms according to relevant law and regulations such as the law about life ethics and safety
- cases with no or little clinical and pathologic information
- cases after February 2013 without written consent forms
Study & Design
- Study Type
- Observational Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Areas with cancerous cells in the pathology slide image
- Secondary Outcome Measures
Name Time Method ot Applicable
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.